Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | CFZ533 | - | - | - | - | [4] 11 11, 46, 49, 53 |
| 2 | CFZ533 (iscalimab) | [1] Iscalimab Iscalimab | [1] D11610
D11610
| [1] CD40 CD40 💬 | [17] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬 | [1] 53 53 |
| 3 | CFZ533 active - Cohort 1 | - | - | - | - | [1] 53 53 |
| 4 | CFZ533 active - Cohort 2 | - | - | - | - | [1] 53 53 |
| 5 | CFZ533 active - Cohort 3 | - | - | - | - | [1] 53 53 |
| 6 | CFZ533 active -Cohort 3 | - | - | - | - | [1] 53 53 |